Check out the FAQ,Terms of Service & Disclaimers by clicking the
link. Please register
to be able to post. By viewing this site you are agreeing to our Terms of Service and Acknowledge our Disclaimers.
FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster.
The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website.
By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.
Nature journals reveal terms of landmark open-access option
24 NOVEMBER 2020
Publisher Springer Nature has announced how scientists can make their papers in its most selective titles free to read as soon as they are published — part of a long-awaited move to offer open-access publishing in the Nature family of journals.
From 2021, the publisher will charge €9,500, US$11,390 or ?8,290 to make a paper open access (OA) in Nature and 32 other journals that currently keep most of their articles behind paywalls and are financed by subscriptions.
... No other journals charge as much as €9,500 per OA paper: the highest fees elsewhere are less than $6,000 (about €5,000). Some OA advocates criticize Springer Nature’s fee as too high.
20M vaccinated in USA this year, then 25-30 every month, I read.
2 doses 28 days apart and (full) immunity starts 14d after dose 2
Some weeks ago the top German vaccine official said he didn't expect significant effects from vaccination
before 2022 and 100000 vaccinations (=-= 400000 in USA ?) per day were already "challenging"
And Fauci didn't expect reduced transmission from the first vaccines, just reduced severety.
So, what's the current expectation in USA ?
the antigen tests - that's another issue. They are being used in several locations in Europe.
Most notably Slovakia, Liverpool.
Spain reports daily the antigen tests , Madrid uses them since early Oct.
>70% of their tests were antigen-tests some weeks ago, now declining to 50%
Madrid PCR,Antigen
Prof. Kekule in his podcast said he hopes/believes >50% of Germans can be vaccinated
until fall 2021 so there would be no fall-wave as this year.
I have seen no comments on Mertens' predictions.
(RKI should say something ?!?)
--------------------------------------
on Dec02 Mertens, warns again about vaccine euphoria.
He reiterates that vaccinating the whole German population cannot be done in 2021
Assuming 150000 or 200000 vaccinations per day, 6 days per week.
Dr Anthony Fauci made the point on Monday as at least four vaccine candidates near the end of clinical trials and the US reported a record number of new cases in the last week.
Please understand that this article is about the personal account of a pharmacist and not necessarily a credible source but there are multiple media reports and apparently the patient was interviewed on MBC Masr.
Given the widespread reports and some studies that confirm people can get a second COVID infection, it only makes sense that they can get it a third time. That the third infection is worse in this case than the first two is concerning, if true:
Over 40 million people have already recovered from the coronavirus after having been infected during the last few months. Following each recovery, most
The first two positive RNA tests might not have indicated a true infection. Does she describe actually getting ill around the time of the first two tests? Sharon posted a link to a virologist's video about his own false positive test.
She does reveal she had her thyroid removed some time ago, so if she does have an immunity problem, that could be related.
"Furthermore, a small-scale, non-randomized trial demonstrated that the administration
of regular boluses of vitamin D3 before the infection was associated with better survival
and less severe disease among older, frail patients with COVID-19."
"the findings should be also confined to the dose and supplementation
strategy used in this trial."
So the right bolus of vita D should have been one of the C.D.C's recommendations since the start of the crisis. In their last recommendation, in particular, for the Christmas party, this is not the case.
The new president of the CDC will explain to us the why of this lack when?
How much did the failure to report this possible cost the United States?
I ask the question of the number, because you like to produce numbers in the United States ...
in the Danish "SH1" strain with N439K there is a subvariant with a 6bp-deletion in the spike protein
position 21764-21769 into Wuhan-HU-1.
21 out of 33 SH1-sequence from Germany have the deletion (and 5 additional mutations of that variant)
1884 out of 2649 from UK have the deletion
The first is from Aug02
{typo, first word above = Monthly, not Mothly}
corrections/updates will be here : http://magictour.free.fr/20a.eu1
I found this recent review on ivermectin data, which looks interesting and appears to have some very positive data behind it, albeit a lot of it is pre full publication.. However, I suspect that as it is a generic and not licensed or produced in some countries e.g. the UK for any indication that this may get overlooked as it will be of little interest to the mainstream Pharma sector.
There needs to be some high quality trials undertaken very rapidly to take a proper look at this compound, but I am not able to determine if there are any of a suitable design, size or quality underway. What do we think? We do still need compounds that will fill the gap around vaccines (limitations in production capacity and roll outs), especially if (as per gsgs' post above) we get a rapid vaccine escape.
Last edited by Vibrant62; December 8, 2020, 07:58 AM.
Comment